Bharat Biotech

Showing of 1 - 20 from 187 results
Bharat Biotech - Total results - 187
Making of Covaxin: How ICMR decided to collaborate with Bharat Biotech for indigenous COVID-19 vaccine
India

Making of Covaxin: How ICMR decided to collaborate with Bharat Biotech for indigenous COVID-19 vaccine

Bharat Biotech already had a track record of producing a range of vaccines for neglected diseases such as rotavirus and typhoid

Bharat Biotech's Covaxin's phase three data shows 65.2% efficacy against Delta variant of COVID-19, says Lancet
Health

Bharat Biotech's Covaxin's phase three data shows 65.2% efficacy against Delta variant of COVID-19, says Lancet

The findings in the medical journal also revealed that the Indian-made vaccine showed 70.8% efficacy against all coronavirus variants

WHO's approval to Covaxin to significantly ease travel for vaccinated Indians, says MEA
India

WHO's approval to Covaxin to significantly ease travel for vaccinated Indians, says MEA

Some countries had issued individual orders for individual vaccines and they perhaps need to issue separate orders for approving Covaxin, Bagchi said

COVID-19 vaccine booster dose required if virus mutates, says Bharat Biotech chairman Krishna Ella
India

COVID-19 vaccine booster dose required if virus mutates, says Bharat Biotech chairman Krishna Ella

Dr Ella further said that wearing a mask will prove to be a weapon against the transmission of the COVID-19 virus

Switzerland recognises Covaxin, United Kingdom may follow shortly: Report
World

Switzerland recognises Covaxin, United Kingdom may follow shortly: Report

About 16 countries have already accepted the vaccine for the purpose of allowing vaccinated travellers from India

Covaxin gets WHO nod for emergency use; a timeline of EUL for India-made COVID-19 vaccine
India

Covaxin gets WHO nod for emergency use; a timeline of EUL for India-made COVID-19 vaccine

The WHO clearance for Covaxin is significant because it means that the 'made-in-India' vaccine will finally be recognised by foreign governments and Indians travelling abroad won't need to self-quarantine or face other travel restrictions

Australia adds India's Covaxin to its list of approved COVID-19 vaccines
India

Australia adds India's Covaxin to its list of approved COVID-19 vaccines

The move will have significant impacts for the return of international students, and travel of skilled and unskilled workers to Australia

Narendra Modi meets Indian COVID-19 vaccine makers, lauds them for 'big role' in country's success
India

Narendra Modi meets Indian COVID-19 vaccine makers, lauds them for 'big role' in country's success

Representatives from seven vaccine makers — Serum Institute of India, Bharat Biotech, Dr Reddy's Laboratories, Zydus Cadila, Biological E, Gennova Biopharma and Panacea Biotech — participated in the meeting

Cannot cut corners while recommending a vaccine, WHO seeks more information from Bharat Biotech
science

Cannot cut corners while recommending a vaccine, WHO seeks more information from Bharat Biotech

Hyderabad-based Bharat Biotech, which has developed Covaxin, had submitted EOI to the WHO on 19 April for the vaccine's Emergency Use Listing.

Can't cut corners, expecting more information from Bharat Biotech regarding Covaxin, says WHO
India

Can't cut corners, expecting more information from Bharat Biotech regarding Covaxin, says WHO

This, a day after Soumya Swaminathan said that the agency's technical advisory group will meet on 26 October to consider the emergency use listing of Covaxin

WHO's advisory group to meet on 26 Oct to decide on EUL for Covaxin says chief scientist Soumya Swaminathan
India

WHO's advisory group to meet on 26 Oct to decide on EUL for Covaxin says chief scientist Soumya Swaminathan

The approval for the vaccine is much awaited, especially by students, medical tourists, business travellers and people with international travel plans and has been in the works since July.

WHO's advisory group to meet on 26 October to consider emergency use for Covaxin
India

WHO's advisory group to meet on 26 October to consider emergency use for Covaxin

Taking to Twitter, Swaminathan said the WHO has been working closely with Bharat Biotech to complete the dossier.

SEC recommends DCGI to approve Bharat Biotech's Covaxin for children between 2-18 years of age
India

SEC recommends DCGI to approve Bharat Biotech's Covaxin for children between 2-18 years of age

If approved, the two-dose vaccine will be given to children within 20 days apart.

Bharat Biotech submits vaccine data for phase 2/3 trials on children between 2-18 years to DCGI
India

Bharat Biotech submits vaccine data for phase 2/3 trials on children between 2-18 years to DCGI

The paediatric Covaxin is similar to the one administered to adults - two doses of the vaccine given 28 days apart.

WHO decision on Bharat Biotech's Covaxin emergency use listing likely next week
India

WHO decision on Bharat Biotech's Covaxin emergency use listing likely next week

The Strategic Advisory Group of Experts on Immunization of the WHO met on Tuesday to make its recommendations on Covaxin on EUL, among other issues

Bharat Biotech's Covaxin likely to receive WHO nod for Emergency Use Listing this month: Health experts
India

Bharat Biotech's Covaxin likely to receive WHO nod for Emergency Use Listing this month: Health experts

WHO's Strategic Advisory Group of Expert on Immunization will be conducting a meeting on 5 October regarding EUL to Covaxin

WHO to decide on Bharat Biotech's emergency approval for Covaxin in October
India

WHO to decide on Bharat Biotech's emergency approval for Covaxin in October

The status of the assessment for Covaxin is ongoing. Bharat Biotech had submitted EOI (Expression of Interest) on 19 April for its COVID-19 vaccine.

COVID-19: WHO's emergency use authorisation for Covaxin delayed again over technical queries
India

COVID-19: WHO's emergency use authorisation for Covaxin delayed again over technical queries

Without the EUA, Covaxin will not be considered an accepted vaccine by most countries around the world, making it difficult for Indians who have taken the dose to travel internationally.

Covaxin's WHO approval delayed; India-made COVID-19 shot may now get EUL in Oct
India

Covaxin's WHO approval delayed; India-made COVID-19 shot may now get EUL in Oct

Bharat Biotech recently said it has submitted all data pertaining to Covaxin to the WHO for EUL and is awaiting feedback from the global health watchdog

Pfizer, Moderna vaccines got  nod before Delta-dominant second wave peak: Bharat Biotech head
India

Pfizer, Moderna vaccines got nod before Delta-dominant second wave peak: Bharat Biotech head

The Delta variant is known to be more virulent than the earlier strains of SARS-CoV2